US-based drugmaker Pfizer and Indian biotechnology major Bicon today said they have agreed to end their alliance to sell insulin and insulin analog products made by the Indian company.
Biotechnology major Biocon India Ltd plans to invest over Rs 500 crore on its expansion plans over the next two years.
If the initial analysis of this YJ-21 is correct, then China becomes the first country in the world to operationally field such a missile from a naval vessel.
But Down Under is a tough call due to shipment time and quality control issues.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances